Company Optigrade News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data confirm strong anticancer activity of two lead compounds in CT-01 programResults support advancement of CT-01 compounds towards IND expected in late.

Jakub radzewiczBevacizumab avastinAtezolizumab tecentriqGuillaume van renterghemCompany optigradeInternational investor relationsChief executive officerInvestigational new drug applicationCaptor therapeuticOverall survivalOverall response rateTargeted protein degradationCaptor therapeuticsInvestor relationsWarsaw stock exchange ctxCaptor therapeutics